Exchange: NYSE
Industry: Food & Drug Retailers
Last Trade: 4:03 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 2.12 | 1.48 | 43.39 |
| EPS, GAAP | 2.08 | 1.60 | 1.60 |
| Consensus Estimate | 2.05 | 1.60 | 28.09 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 6.11 | 4.86 | 25.60 |
| EPS, GAAP | 5.59 | 4.57 | 22.30 |
| Consensus Estimate | 6.39 | 4.97 | 28.59 |
| MCK | Industry Average | |
| P/E (TTM) | 15.56 | NA |
| P/E (Forward) | 12.05 | NA |
| PEG Ratio | 0.87 | 1.09 |
| Price/Sales | 0.17 | 0.47 |
| Beta | 0.74 | 0.83 |
| 5:00 PM | 4/30/2012 | McKesson 4Q Profit Up 23% On Growth At Distribution Unit |
| 1:27 PM | 4/26/2012 | UPDATE: McKesson Agrees To Settle Drug Mark-Up Claims For $190 Million |
| 5/7/2012 | Barron's 500 (Barrons.com) |
| 5/1/2012 | Stocks to Watch: PLX Tech, PF Chang's, Sears Holdings (WSJ.com) |
| 5/1/2012 | Health-Care Stocks on Sale (Barrons.com) |
| 4/30/2012 | Shutterfly rallies, Anadarko higher after hours (MarketWatch.com) |
| 4/26/2012 | McKesson to pay $190 million in drug-price pact (MarketWatch.com) |
| 4/26/2012 | McKesson to Settle Drug Mark-Up Claims (WSJ.com) |
| 4/24/2012 | Cashing In on Distress (WSJ.com) |
| 4/12/2012 | McKesson Gets Its Marching Orders (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
